Cancer patient dies after Ziopharm experimental drug therapy Ziopharm Oncology Inc said a brain cancer patient died of cranial bleeding about two weeks after starting treatment with the gene therapy developer's lead experimental drug, sending its stock down as much as 16 percent on Friday.
E-cigarettes could cut smoking-related deaths by 21 percent: study E-cigarettes could lead to a 21 percent drop in deaths from smoking-related diseases in those born after 1997, according to a study published in Nicotine & Tobacco Research.
UCLA study finds why some cancers stop responding to immunotherapy Researchers have for the first time identified mechanisms that enable advanced melanoma to become resistant to a new class of drugs, known as immunotherapies, which work by enlisting the body's own immune system to fight the disease.
Antipsychotic drug also relieves nausea from cancer chemotherapy Adding the cheap antipsychotic drug olanzapine to conventional anti-vomiting medicine can help prevent nausea in cancer patients, according to a new test of 380 volunteers.
Juno being sued over leukemia drug study NEW YORK (AP) — Juno Therapeutics and its CEO, Hans E. Bishop, are being named in a lawsuit over whether the biotechnology company misled investors about the death of a patient in a key study involving its drug intended to treat leukemia.
Take precautions during laser hair removal, researchers advise The smelly "burning hair" smoke released during laser hair removal could be a health hazard, especially for people with heavy exposure to it, researchers report.
Soda and other sweet drinks tied to risk for some rare cancers People who drink lots of soda or other sugary beverages may have a higher risk of developing rare cancers in the gallbladder and bile ducts around the liver, a Swedish study suggests.
Unrealistic expectations may hinder blood cancer patients' care The biggest barrier to high-quality end-of-life care for patients with blood cancers may be unrealistic expectations, a new survey found.
Skin cancer risk for freckly red-heads equivalent to 21 years in sun Having genes that give you red hair, pale skin and freckles increases your risk of developing skin cancer as much as an extra 21 years' exposure to the sun, researchers said on Tuesday.
Cancer hospital advertising triples since 2005 Between 2005 and 2014, U.S. cancer centers upped their spending on ads targeting the general public, with 890 centers spending $173 million on ads by 2014, according to a new analysis.
